I-Corps at NIH is an entrepreneurship training program specifically designed for companies that received Small Business Innovation Research or Small Business Technology Transfer funding from NIH and the Centers for Disease Control and Prevention (CDC). During this 8-week, hands-on program, you'll learn how to focus your business plan and get the tools to bring your treatment to the patients who need it most. And there's no cost to you — a $55,000 supplement covers program costs.
TABA Funding is part of a comprehensive NIH program intended to help small businesses identify and address their most pressing product development needs. TABA programs assist small businesses in: making better technical decisions concerning such projects; solving technical problems which arise during the conduct of such projects; minimizing technical risks associated with such projects; and developing and commercializing new commercial products and processes resulting from such projects, including intellectual property protections.
The TABA Needs Assessment Report provides a third-party, unbiased assessment of a Phase I project's progress in technical and business areas that are critical to success in the competitive healthcare marketplace. There is no cost for this Report and the time commitment for participation is minimal.
Catalyze is a new approach to translational research support that takes into consideration not only the technical needs of the project, but also the management, commercialization, regulatory, and training requirements of the scientists developing them. Catalyze strives to anticipate the needs of a supported project, pivot funding and other support as needed, and prevent projects from failing for non-technical reasons. Projects supported by Catalyze receive funding, project management support, access to technical services and expertise, advisory services (IP, regulatory, commercialization), training opportunities, access to best practices and the opportunity to become part of an innovation network.
The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.
SBIR or STTR-supported projects may benefit from funding and support above and beyond the Phase II or Phase IIB awards. The Commercialization Readiness Pilot Program (CRP) provides additional technical assistance and late-stage research and development support not typically covered within small business awards to help products get to market.
Learn more about...